Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Current Deferred Revenue (2020 - 2025)

iSpecimen (ISPC) has 6 years of Current Deferred Revenue data on record, last reported at $155506.0 in Q3 2025.

  • For Q3 2025, Current Deferred Revenue fell 45.16% year-over-year to $155506.0; the TTM value through Sep 2025 reached $155506.0, down 45.16%, while the annual FY2024 figure was $360708.0, 13.24% down from the prior year.
  • Current Deferred Revenue reached $155506.0 in Q3 2025 per ISPC's latest filing, down from $164066.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $802860.0 in Q2 2021 and bottomed at $46910.0 in Q3 2023.
  • Average Current Deferred Revenue over 5 years is $330971.4, with a median of $272681.0 recorded in 2024.
  • Peak YoY movement for Current Deferred Revenue: tumbled 82.79% in 2023, then skyrocketed 504.5% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $654746.0 in 2021, then crashed by 79.79% to $132335.0 in 2022, then surged by 214.18% to $415771.0 in 2023, then fell by 13.24% to $360708.0 in 2024, then plummeted by 56.89% to $155506.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $155506.0 in Q3 2025, $164066.0 in Q2 2025, and $270208.0 in Q1 2025.